ArticleFrontiers in pharmacology2021
Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD.
Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 17 citations in OpenAlex.
- Insights from Real-World Evidence on the Use of Inhalers in Clinical Practice.Journal of clinical medicine · 2025Article
- Evolution of Peak Inspiratory Flow During Hospitalization of Patients with COPD - A Prospective Monocentric Observational Study.International journal of chronic obstructive pulmonary disease · 2025Observational
- Prevalence of Critical Errors and Insufficient Peak Inspiratory Flow in Patients Hospitalized with COPD in a Department of General Internal Medicine: A Cross-Sectional Study.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2024Article
- Clinical characteristics of chronic obstructive pulmonary disease patients with superoptimal peak inspiratory flow rate.Scientific reports · 2024Article
- Suboptimal peak inspiratory flow rate: a noticeable risk factor for inhaler concordance in patients with chronic airway diseases.BMJ open respiratory research · 2024Observational
- Aerosol Plumes of Inhalers Used in COPD.Pulmonary therapy · 2024Article
- Inhaler personalisation based on peak inspiratory flow (PIF) among dry powder inhaler users: a pilot randomised control trial (RCT) in COPD.Journal of pharmaceutical policy and practice · 2024Article
- Respiratory function in healthy long-term meditators: A cross-sectional comparative study.Heliyon · 2023Article
- Evaluation of Peak Inspiratory Flow Rate in Hospitalized Palliative Care Patients with COPD.Pharmacy (Basel, Switzerland) · 2023Article
- Standardized inhalation capability assessment: A key to optimal inhaler selection for inhalation therapy.Journal of translational internal medicine · 2023Article
- High Prevalence of Suboptimal Peak Inspiratory Flow in Hospitalized Patients With COPD: A Real-world Study.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2022Article
- Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.NPJ primary care respiratory medicine · 2022Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Optimal peak inspiratory flow rate (PIFR) is crucial for inhalation therapy in patients with chronic obstructive pulmonary disease (COPD). However, little is known about the impact of PIFR-guided inhalation therapy on the clinical outcomes among patients with varying severities of COPD. A PIFR-guided inhalation therapy, including PIFR assessment and PIFR-guided inhaler education, was introduced in a pay-for-performance COPD management program in National Taiwan University Hospital. Among 383 COPD patients, there was significant reduction in incidence of severe acute exacerbation in the PIFR-guided inhalation therapy (PIFR group) than conventional inhaler education (control group) (11.9 vs. 21.1%,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.